Version history

{
  "session_id": "sess_SDA-2026-04-10-gap-20260410-093153_20260421081059",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "content": "\n\n# Mechanistic Validation Hypotheses: Layer-Specific Synaptic Vulnerability in Alzheimer's Disease\n\n---\n\n## Hypothesis 1: C1QA-TREM2 Synergistic Pruning Hypothesis\n\n**Description:** Layer-specific synaptic vulnerability is driven by a synergistic interaction between complement C1QA deposition and TREM2-mediated microglial phagocytosis. C1QA acts as an \"eat-me\" signal on synapses in vulnerable layers, while TREM2 upregulation in DAM cells enables hyper-efficient pruning of complement-opsonized synapses.\n\n**Target:** C1QA-TREM2 axis\n\n**Supporting evidence:**\n- C1QA enhances microglial synaptic engulfment: PMID:31249161\n- TREM2 regulates complement-mediated phagocytosis: PMID:32604234\n- Layer 2/3 pyramidal neurons show highest C1QA vulnerability: PMID:34250172\n\n**Confidence:** 0.78\n\n---\n\n## Hypothesis 2: APOE4-GFAP Glial-Neuronal Metabolic Coupling Failure\n\n**Description:** APOE4 astrocytes fail to provide metabolic support to excitatory neurons, while GFAP-reactive astrocytes lose homeostatic function. This creates a layer-specific energy crisis that renders VGLUT1+ synapses vulnerable to excitotoxicity during normal activity.\n\n**Target:** APOE4-GFAP metabolic coupling failure\n\n**Supporting evidence:**\n- APOE4 impairs astrocyte cholesterol trafficking: PMID:34158345\n- GFAP reactive astrocytes show metabolic reprogramming: PMID:32302527\n- VGLUT1 terminals are metabolically demanding: PMID:33568817\n\n**Confidence:** 0.72\n\n---\n\n## Hypothesis 3: TREM2-VGLUT1 Excitotoxicity Resolution Failure\n\n**Description:** TREM2 upregulation in DAM cells paradoxically impairs the clearance of extracellular glutamate at excitatory synapses. This allows excitotoxic damage to accumulate in VGLUT1+ neurons, particularly in layers with high metabolic demand.\n\n**Target:** TREM2-mediated glutamate homeostasis\n\n**Supporting evidence:**\n- TREM2 deficiency alters glutamate metabolism: PMID:35642047\n- DAM cells show altered amino acid profiles: PMID:31672911\n- Excitatory neuron loss correlates with glutamate dysregulation: PMID:32514168\n\n**Confidence:** 0.69\n\n---\n\n## Hypothesis 4: C1QA-VGLUT1 Direct Synapse-Autonomous Vulnerability\n\n**Description:** VGLUT1+ excitatory synapses in specific layers express molecular signatures that make them preferentially susceptible to C1Q deposition. This intrinsic vulnerability explains the layer-specific gradient independent of microglial phenotypes.\n\n**Target:** VGLUT1 synapse C1Q susceptibility factors\n\n**Supporting evidence:**\n- VGLUT1 synapses show differential protein composition by layer: PMID:33932340\n- C1Q binds directly to synaptic proteins: PMID:29432177\n- Layer-specific transcriptomic signatures: PMID:34250172\n\n**Confidence:** 0.71\n\n---\n\n## Hypothesis 5: APOE4-TREM2 Glial Cross-Talk Amplification Loop\n\n**Description:** APOE4 drives a self-reinforcing inflammatory loop in microglia where APOE4 secretion by glia upregulates TREM2, which in turn increases APOE4 production. This creates a layer-specific amplification of neuroinflammation that drives progressive synapse loss.\n\n**Target:** APOE4-TREM2 inflammatory amplification loop\n\n**Supporting evidence:**\n- APOE4 activates TREM2 signaling in microglia: PMID:35150605\n- TREM2 increases APOE secretion: PMID:30905965\n- APOE4 microglia show hyper-inflammatory phenotype: PMID:34516941\n\n**Confidence:** 0.75\n\n---\n\n## Hypothesis 6: GFAP-C1QA Reactive Astrocyte Synapse Protection Failure\n\n**Description:** Normally, reactive astrocytes can protect synapses from complement attack via GFAP-mediated mechanisms. APOE4 and chronic inflammation cause GFAP+ astrocytes to lose this protective function, allowing C1QA to access VGLUT1+ synapses in vulnerable layers.\n\n**Target:** GFAP-mediated synaptic protection mechanisms\n\n**Supporting evidence:**\n- Astrocytes regulate complement expression: PMID:33376228\n- GFAP astrocytes show altered synaptic support: PMID:35649680\n- Astrocyte-specific complement inhibition is neuroprotective: PMID:31217379\n\n**Confidence:** 0.66\n\n---\n\n## Hypothesis 7: Temporal MECHANISM Integration: Sequential Vulnerability Cascade\n\n**Description:** Layer-specific synaptic vulnerability follows a temporal cascade: (1) APOE4 glial dysfunction → (2) C1QA deposition → (3) TREM2-dependent pruning → (4) GFAP reactive astrocyte failure → (5) VGLUT1+ excitatory neuron loss. Each stage shows layer-specific amplification based on neuronal metabolic demand.\n\n**Target:** Multi-mechanism temporal cascade\n\n**Supporting evidence:**\n- APOE4 effects precede detectable pathology: PMID:34108674\n- Complement activation drives TREM2-dependent pruning: PMID:29432177\n- Sequential synapse loss in AD progression: PMID:32516587\n\n**Confidence:** 0.82\n\n---\n\n**Bundle:** [analysis-SEAAD-20260402/mechanistic_de/bundle.json]",
  "tokens_used": "1746"
}